Lamivudine/Adefovir group Lamivudine 100mg is administered orally once daily. When resistant virus is appearance or lamivudine is not insufficient, patients are added 10mg of adefovir dipivoxil once
Sponsors
University of Tokyo Department of Gastroenterology, Faculty of Medicine
Conditions
Chronic hepatitis B
Unknown Phase
A comparison of lamivudine plus adefovir and entecavir for chronic hepatitis B patients who had not previously received a nucleoside analogue: A randomized trial
Active, not recruitingJPRN-UMIN000000884
Start: 2007-07-01Target: 200Updated: 2026-06-29
A comparison of lamivudine plus adefovir and entecavir for chronic hepatitis B patients whose HBV DNA levels are below the level of detection by PCR
Active, not recruitingJPRN-UMIN000000898
Start: 2007-11-01Target: 200Updated: 2026-06-29